I don’t think it does. With dengue fever the issue is once you develop antibodies the first time, the second time you get infected the antibodies actually incre

I don’t think it does. With dengue fever the issue is once you develop antibodies the first time, the second time you get infected the antibodies actually increase the viruses chances of binding to whatever it binds to, so the effectiveness of the virus increases. I’m not sure how mRNA vaccines get around that, but I imagine they have a plan, it would be interesting to hear it.